Back
MercadoLibre Vs. Akero Therapeutics Industry Stock Comparison
Buy
77
MELI
MercadoLibre
Last Price:
$2,259.35
Seasonality Move:
15.43%
Buy
59
AKRO
Akero Therapeutics
Last Price:
$51.82
Seasonality Move:
-12.73%
Buy
77
MercadoLibre (MELI)
is a Buy
Is MercadoLibre a Buy, Sell or Hold?
-
The current MercadoLibre [MELI] share price is $2,260.00. The Score for MELI is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
-
MELI is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
59
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $51.79. The Score for AKRO is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MELI Stock Price Chart
What is MercadoLibre's stock price today?
-
The MercadoLibre share price today is $2,260.00Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MELI is experiencing selling pressure, which indicates risk of future bearish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $51.79Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing slight selling pressure.
MELI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 80.94 | Buy |
Relative Strength Index (14 RSI): | 78.6 | Buy |
Chaikin Money Flow: | -683765 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1853.63 - 2080.33) | Buy |
Bollinger Bands (100): | (1812.75 - 2066.35) | Buy |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.23 | Buy |
Relative Strength Index (14 RSI): | 65.31 | Buy |
Chaikin Money Flow: | -120893 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (34.17 - 57.71) | Buy |
Bollinger Bands (100): | (24.28 - 43.14) | Buy |
MELI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2096.63 | Buy |
20-day SMA: | 2000.97 | Buy |
50-day SMA: | 1871.04 | Buy |
200-day SMA: | 1865.11 | Buy |
8-day EMA: | 2109.17 | Buy |
20-day EMA: | 2020.4 | Buy |
50-day EMA: | 1943.79 | Buy |
200-day EMA: | 1844.34 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 50.2 | Buy |
20-day SMA: | 51.13 | Buy |
50-day SMA: | 36.86 | Buy |
200-day SMA: | 28.92 | Buy |
8-day EMA: | 50.79 | Buy |
20-day EMA: | 47.87 | Buy |
50-day EMA: | 40.71 | Buy |
200-day EMA: | 31.81 | Buy |
MercadoLibre Earnings Growth & MELI Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.04 per share, an increase next quarter of $0.38 per share, an increase this year of $12.27 per share, and an increase next year of $16.89 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $0.10 per share.
MercadoLibre Technical Analysis
Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |